Evidence map›Paper›PMID 31478072›Full record

ArticleClinical research in cardiology : official journal of the German Cardiac Society2020

Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis utilizing the next-generation fully retrievable and repositionable valve system: mid-term results from a prospective multicentre registry.

Janusz Kochman, Karol Zbroński, Łukasz Kołtowski, Radosław Parma, Andrzej Ochała, Zenon Huczek, Bartosz Rymuza, Radosław Wilimski, Maciej Dąbrowski, Adam Witkowski and 4 more

Open access · hybridAbstract readMulticenter Study
In one paragraph

Article in Clinical research in cardiology : official journal of the German Cardiac Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Cerebrovascular Events in Aortic Stenosis: From Native Valve Disease to TAVR-Specific Risk and Prevention.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Mid-term outcomes of patients with Lotus and Evolut transcatheter valves.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2022
    Article
  7. Review
  8. Kidney injury as post-interventional complication of TAVI.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Review
  9. Comparison of the results of transcatheter aortic valve implantation in patients with bicuspid and tricuspid aortic valve.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2021
    Article
  10. Machine learning-based risk prediction of intrahospital clinical outcomes in patients undergoing TAVI.Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Article
  11. Periprocedural embolisation of a Sapien 3 TAVI prosthesis: failure and success.Clinical research in cardiology : official journal of the German Cardiac Society · 2020
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Janusz KochmanFirst Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, PL, 02-097, Warsaw, Poland.
Karol ZbrońskiFirst Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, PL, 02-097, Warsaw, Poland. karol.zbronski@gmail.com.ORCID http://orcid.org/0000-0002-4428-8208
Łukasz KołtowskiFirst Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, PL, 02-097, Warsaw, Poland.
Radosław ParmaMedical University of Silesia, Katowice, Poland.
Andrzej OchałaMedical University of Silesia, Katowice, Poland.
Zenon HuczekFirst Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, PL, 02-097, Warsaw, Poland.
Bartosz RymuzaFirst Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, PL, 02-097, Warsaw, Poland.
Radosław WilimskiDepartment of Cardiac Surgery, Medical University of Warsaw, Warsaw, Poland.
Maciej DąbrowskiDepartment of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.
Adam WitkowskiDepartment of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.
Piotr ScisłoFirst Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, PL, 02-097, Warsaw, Poland.
Marek GrygierDepartment of Cardiology, Poznan University of Medical Science, Poznan, Poland.
Maciej LesiakDepartment of Cardiology, Poznan University of Medical Science, Poznan, Poland.
Grzegorz OpolskiFirst Department of Cardiology, Medical University of Warsaw, ul. Banacha 1a, PL, 02-097, Warsaw, Poland.
Medical University of Warsaw · PLInstitute of Cardiology · PLMedical University of Silesia · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe aim of this study was to evaluate the outcomes of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve (BiAV) stenosis using a mechanically expanded Lotus™ device. The prior experience with first-generation devices showed disappointing results mainly due to increased prevalence of aortic regurgitation (AR) that exceeded those observed in tricuspid stenosis. METHODS AND

resultsWe collected baseline, in-hospital, 30-day and 2-year follow-up data from a prospective, multicentre registry of patients with BiAV undergoing TAVI using Lotus™ valve. Safety and efficacy endpoints were assessed according to VARC-2 criteria. The study group comprised 24 patients. The mean age was 73.5 years and the mean EuroSCORE 2 was 4.35 ± 2.56%. MDCT analysis revealed Type 1 BiAV in 75% of patients. The mean gradient decreased from 60.1 ± 18.3 to 15 ± 6.4 mm Hg, the AVA increased from 0.6 ± 0.19 to 1.7 ± 0.21 cm

Indexed as

AgedAged, 80 and overAortic Valve InsufficiencyAortic Valve StenosisBicuspid Aortic Valve DiseaseFemaleHumansMalePostoperative ComplicationsProspective StudiesProsthesis DesignRegistriesTranscatheter Aortic Valve ReplacementTreatment OutcomeBicuspid aortic valveLotus™ valveTranscatheter aortic valve implantation

Identifiers

PMID31478072
PMCPMC7182541
OpenAlexW2971571931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.